XML 56 R83.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments And Contingencies (Schedule Of Activity Related To Asbestos Claims) (Details) (Asbestos Commitments And Contingencies [Member], USD $)
12 Months Ended
Dec. 31, 2013
Claim
Dec. 31, 2012
Claim
Dec. 31, 2011
Claim
Dec. 31, 2010
Claim
Dec. 31, 2013
Maritime Claims [Member]
Claim
Dec. 30, 2009
Maritime Claims [Member]
Claim
Feb. 25, 2013
Thomas Amato [Member]
Loss Contingencies [Line Items]              
Jury Verdict             $ 2,500,000
Activity Related to Asbestos Claims [Roll Forward]              
Beginning claims 56,442 58,658 64,839        
New claims 2,950 3,542 3,748        
Settlements (1,142) (1,030) (1,117)        
Dismissals (6,762) (4,919) (11,059)        
Number Of Activated Maritime Claims 2 191 2,247        
MARDOC claims 3,393 [1]            
Ending claims 51,490 56,442 58,658 64,839      
Total number of maritime claims           36,448  
Claims permanently dismissed         26,562    
Maritime actions       8      
Number_Restored_Dismissed_Maritime_Claims         2,980    
NumberRestoredSettledClaims         225    
Net_Number_Restored_Maritime_Claims         188    
[1] As of January 1, 2010, the Company was named in 36,448 maritime actions which had been administratively dismissed by the United States District Court for the Eastern District of Pennsylvania ("MARDOC claims"), and therefore were not classified as active claims. In addition, the Company was named in 8 new maritime actions in 2010 (also not classified as active claims). Through December 31, 2013, pursuant to an ongoing review process initiated by the Court, 26,562 claims were permanently dismissed, and 3,393 claims were classified as active, of which 2,980 claims were subsequently dismissed, 225 claims were subsequently settled and 188 claims remain active (and have been added to "Ending claims"). By settlement agreement of December 30, 2013, the Company resolved all of the remaining MARDOC claims with plaintiffs’ counsel. The agreement will result in the dismissal of all MARDOC claims against the Company.